Background Myocardial extravascular extracellular volume fraction (Ve) measures quantify
diffuse fibrosis not readily detectable by conventional late gadolinium (Gd) enhancement …

Objectives: This study aimed to test the characteristics of the myocardial extracellular volume
fraction (ECV) derived from pre-and post-contrast T1 measurements among healthy …

Abstract Background Gadolinium (Gd) Extracellular volume fraction (ECV) by
Cardiovascular Magnetic Resonance (CMR) has been proposed as a non-invasive method …

Background—Diffuse myocardial fibrosis is a final end point in most cardiac diseases. It is
missed by the cardiovascular magnetic resonance (CMR) late gadolinium enhancement …

Background Diffuse myocardial fibrosis, and to a lesser extent global myocardial edema, are
important processes in heart disease which are difficult to assess or quantify with …

Background: Cardiac magnetic resonance techniques permit quantification of the
myocardial extracellular volume fraction (ECV), representing a surrogate marker of reactive …

Aims Conventional late gadolinium enhancement (LGE) cardiac magnetic resonance can
detect myocardial infarction and some forms of non-ischaemic myocardial fibrosis. However …

Background Disturbances in the myocardial extracellular volume fraction (ECV), such as
diffuse or focal myocardial fibrosis or edema, are hallmarks of heart disease. Diffuse ECV …

Objective To measure and assess the significance of myocardial extracellular volume (ECV),
determined non-invasively by equilibrium contrast cardiovascular magnetic resonance, as a …

Background—Extracellular matrix expansion is a key element of ventricular remodeling and
a potential therapeutic target. Cardiovascular magnetic resonance (CMR) T1-mapping …